IgE-reactivity to seven Malassezia species

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 58, Issue 4, 2003, Pages 306-311

  Zargari, Arezou ^a,d   Midgley, G ^b   Back O ^c   Johansson, S G O ^d   Scheynius, A ^d  

^a LUDWIG INSTITUTE FOR CANCER RESEARCH   (Sweden)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c LUND UNIVERSITY HOSPITAL   (Sweden)

^d KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Atopic eczema dermatitis syndrome; ImmunoCAP

Indexed keywords

ALLERGEN; IMMUNOGLOBULIN E; IMMUNOGLOBULIN E ANTIBODY;

ADULT; ARTICLE; ATOPIC DERMATITIS; DIAGNOSTIC KIT; FEMALE; HUMAN; IMMUNOASSAY; IMMUNOBLOTTING; IMMUNOREACTIVITY; INHIBITION KINETICS; MAJOR CLINICAL STUDY; MALASSEZIA; MALE; PRIORITY JOURNAL; PROTEIN ANALYSIS;

ADOLESCENT; ADULT; ANTIBODIES, FUNGAL; DERMATITIS, ATOPIC; FEMALE; HUMANS; IMMUNOBLOTTING; IMMUNOGLOBULIN E; MALASSEZIA; MALE; MIDDLE AGED;

EID: 0038333353     PISSN: 01054538     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1398-9995.2003.00082.x     Document Type: Article

References (36)

1. MIDGLEY G. The diversity of Pityrosporum (Malassezia) yeasts in vivo and in vitro. Mycopathologia 1989;106:143-153.
2. GUEHO E, MIDGLEY G, GUILLOT J. The genus Malassezia with description of four new species. Antonie Van Leeuwenhoek 1996;69:337-355.
3. GUILLOT J, BOND R. Malassezia pachydermatis: a review. Med Mycol 1999;37:295-306.
4. FAERGEMANN J. Pityrosporum species as a cause of allergy and infection. Allergy 1999;54:413-419.
5. FAERGEMANN J, BERGBRANT IM, DOHSE M, SCOTT A, WESTGATE G. Seborrhoeic dermatitis and Pityrosporum (Malassezia) folliculitis: characterization of inflammatory cells and mediators in the skin by immunohistochemistry. Br J Dermatol 2001;144:549-556.
6. CRESPO ERCHIGA V, OJEDA MARTOS A, VERA CASANO A, CRESPO ERCHIGA A, SANCHEZ FAJARDO F. Malassezia globosa as the causative agent of pityriasis versicolor. Br J Dermatol 2000;143:799-803.
7. GUPTA AK, KOHLI Y, FAERGEMANN J, SUMMERBELL RC. Epidemiology of Malassezia yeasts associated with pityriasis versicolor in Ontario, Canada. Med Mycol 2001;39:199-206.
8. WAERSTED A, HJORTH N. Pityrosporum orbiculare a pathogenic factor in atopic dermatitis of the face, scalp and neck? Acta Derm Venereol (Stockh) 1985;114 (Suppl):146-148.
9. KIEFFER M, BERGBRANT IM, FAERGEMANN J, et al. Immune reactions to Pityrosporum ovale in adult patients with atopic and seborrheic dermatitis. J Am Acad Dermatol 1990;22:739-742.
10. WESSELS MW, DOEKES G, VAN IEPEREN-VAN DIJK AG, KOERS WJ, YOUNG E. IgE antibodies to Pityrosporum ovale in atopic dermatitis. Br J Dermatol 1991;125:227-232.
11. NAKABAYASHI A, SEI Y, GUILLOT J. Identification of Malassezia species isolated from patients with seborrhoeic dermatitis, atopic dermatitis, pityriasis versicolor and normal subjects. Med Mycol 2000;38:337-341.
12. NORDVALL SL, JOHANSSON S. IgE antibodies to Pityrosporum orbiculare in children with atopic diseases. Acta Paediatr Scand 1990;79:343-348.
13. SCHEYNIUS A, JOHANSSON C, BUENTKE E, ZARGARI A, LINDER MT. Atopic eczema/dermatitis syndrome and Malassezia. Int Arch Allergy Immunol 2002;127:161-169.
14. JOHANSSON SGO, HOURIHANE JOB, BOUSQUET J, et al. A revised nomenclature for allergy. Allergy 2001;56:813-824.
15. BÄCK O, SCHEYNIUS A, JOHANSSON SGO. Ketoconazole in atopic dermatitis: therapeutic response is correlated with decrease in serum IgE. Arch Dermatol Res 1995;287:448-451.
16. BÄCK O, BARTOSIK J. Systemic ketoconazole for yeast allergic patients with atopic dermatitis. J Europ Acad Dermatol Venereol 2001;15:34-38.
17. MAYSER P, GROSS A. IgE antibodies to Malassezia furfur, M. sympodialis and Pityrosporum orbiculare in patients with atopic dermatitis, seborrheic eczema or pityriasis versicolor, and identification of respective allergens. Acta Derm Venereol 2000;80:357-361.
18. TENGVALL LINDER M, JOHANSSON C, BENGTSSON Å, HOLM L, HÄRFAST B, SCHEYNIUS A. Pityrosporum orbiculare-reactive T-cell lines in atopic dermatitis patients and healthy individuals. Scand J Immunol 1998;47:152-158.
19. TENGVALL LINDER M, JOHANSSON C, SCHEYNIUS A, WAHLGREN C. Positive atopy patch test reactions to Pityrosporum orbiculare in atopic dermatitis patients. Clin Exp Allergy 2000;30:122-131.
20. ZARGARI A, HÄRFAST B, JOHANSSON S, JOHANSSON SGO, SCHEYNIUS A. Identification of allergen components of the opportunistic yeast Pityrosporum orbiculare by monoclonal antibodies. Allergy 1994;49:50-56.
21. HANIFIN J, RAJKA G. Diagnostic features of atopic dermatitis. Acta Derm Venereol 1980;92:44-47.
22. RAJKA G, LANGELAND T. Grading of the severity of atopic dermatitis. Acta Derm Venereol (Stockh) 1989;144 (Suppl):13-14.
23. ZARGARI A, ESHAGHI H, BÄCK O, JOHANSSON SGO, SCHEYNIUS A. Serum IgE reactivity to Malassezia furfur extract and recombinant M. furfur allergens in patients with atopic dermatitis. Acta Derm Venereol 2001;81:418-422.
24. SUGITA T, SUTO H, UNNO T, et al. Molecular analysis of Malassezia microflora on the skin of atopic dermatitis patients and healthy subjects. J Clin Microbiol 2001;39:3486-3489.
25. ARZUMANIAN VG. The yeast Malassezia on the skin of healthy individuals and patients with atopic dermatitis. Vestn Ross Akad Med Nauk 2001;2:29-31.
26. KOYAMA T, KANBE T, ISHIGURO A, KIKUCHI A, TOMITA Y. Antigenic components of Malassezia species for immunoglobulin E antibodies in sera of patients with atopic dermatitis. J Dermatol Sci 2001;26:201-208.
27. ASPIROZ C, MORENO LA, REZUSTA A, RUBIO C. Differentiation of three biotypes of Malassezia species on human normal skin, correspondence with M. globosa, M. sympodialis and M. restricta. Mycopathologia 1999;145:69-74.
28. MAKIMURA K, TAMURA Y, KUDO M, UCHIDA K, SAITO H, YAMAGUCHI H. Species identification and strain typing of Malassezia species stock strains and clinical isolates based on the DNA sequences of nuclear ribosomal internal transcribed spacer 1 regions. J Med Microbiol 2000;49:29-35.
29. MIDGLEY G. The lipophilic yeasts: state of the art and prospects. Med Mycol 2000;38 (Suppl. 1):9-16.
30. GUPTA AK, KOHLI Y, SUMMERBELL RC, FAERGEMANN J. Quantitative culture of Malassezia species from different body sites of individuals with or without dermatoses. Med Mycol 2001;39:243-251.
31. SCHMIDT M, ZARGARI A, HOLT P et al. The complete cDNA sequence and expression of the first major allergenic protein of Malassezia furfur, Mal f 1. Eur J Biochem 1997;246:181-185.
32. LINDBORG M, MAGNUSSON CG, ZARGARI A et al. Selective cloning of allergens from the skin colonizing yeast Malassezia furfur by phage surface display technology. J Invest Dermatol 1999;113:156-161.
33. RASOOL O, ZARGARI A, ALMQVIST J, ESHAGHI H, WHITLEY P, SCHEYNIUS A. Cloning, characterization and expression of complete coding sequences of three IgE binding Malassezia furfur allergens, Mal f 7, Mal f 8 and Mal f 9. Eur J Biochem 2000;267:4355-4361.
34. YASUEDA H, HASHIDA-OKADO T, SAITO A et al. Identification and cloning of two novel allergens from the lipophilic yeast, Malassezia furfur. Biochem Biophys Res Commun 1998;248:240-244.
35. ONISHI Y, KURODA M, YASUEDA H, et al. Two-dimensional electrophoresis of Malassezia allergens for atopic dermatitis and isolation of Mal f 4 homologs with mitochondrial malate dehydrogenase. Eur J Biochem 1999;261:148-154.
36. SUGITA T, TAKASHIMA M, SHINODA T, et al. New yeast species Malassezia dermatis isolated from patients with atopic dermatitis. J Clin Micro 2002;40:1363-1367.